Q4 2021 Holdings
Filed 2022-02-14 | 36 holdings | $60.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $36.9M | 1,529,402 | 60.9% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $13.1M | 340,098 | 21.7% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $7.0M | 105,500 | 11.5% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $2.0M | 500,000 | 3.3% |
| Aclaris Therapeu(ACRS) | COM | 00461U105 | $1.4M | 98,000 | 2.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $25.3K | 535,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $22.9K | 11,736,283 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $9.8K | 419,632 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $9.1K | 404,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.3K | 843,122 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $7.9K | 470,000 | 0.0% |
| Merus BV | COM | N5749R100 | $7.5K | 235,500 | 0.0% |
| Pyxis Oncology Inc Series B(PYXS) | COMMON STOCK | 747324101 | $7.4K | 677,753 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.0K | 225,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.3K | 318,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.5K | 562,500 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 999222ZZ8 | $4.7K | 580,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.5K | 206,126 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $4.5K | 391,974 | 0.0% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $4.2K | 525,000 | 0.0% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $4.1K | 291,884 | 0.0% |
| Seelos Therapeutics Inc | COM | 81577F109 | $4.1K | 2,500,000 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $4.0K | 310,030 | 0.0% |
| Health Sciences Acquisitions | ORD SHS | G4411D109 | $4.0K | 392,500 | 0.0% |
| Verastem Inc | COM | 92337C104 | $3.8K | 1,865,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.5K | 200,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.4K | 179,995 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $3.2K | 230,000 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.0K | 243,072 | 0.0% |
| Mirati Therapeutics(MRTXEUR) | COM | 60468T105 | $2.9K | 20,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $1.5K | 68,500 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $1.4K | 119,843 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $1.3K | 322,500 | 0.0% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $1.2K | 262,500 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $1.1K | 127,500 | 0.0% |
| Nuvation Warrants(NUVB) | *W EXP 07/07/202 | 67080N101 | $172 | 90,832 | 0.0% |